Preventing parasiticide resistance in veterinary medicine is the theme of the 2022 Global Health Summit, which will be held Monday, Aug. 1, during AVMA Convention 2022 in Philadelphia.
Researchers have documented increasing levels of antiparasitic resistance in cattle, small ruminants, swine, poultry, and horses, both globally and within the United States, according to the Food and Drug Administration. There are concerns as well of growing resistance to drugs commonly used in dogs to prevent or treat parasites.
The Global Health Summit offers up to four hours of in-person continuing education programming. Speakers will address a range of topics, including the mechanisms and evolution of resistance to parasiticides, a one-health approach to combating parasiticide resistance, judicious use of parasiticides in veterinary medicine, and future directions in parasite control.
The summit kicks off at 1 p.m. EDT at the Philadelphia Convention Center with Dr. Ray Kaplan’s presentation, “Global Perspective on Parasiticide Resistance in Companion and Production Animals.” Dr. Kaplan is a professor in the Department of Pathobiology at St. George’s University School of Veterinary Medicine in Grenada, West Indies, where he also serves as senior associate dean.
At 2 p.m., Dr. Cassan Pulaski will speak on “Judicious Use Principles for Use of Parasiticides in Veterinary Medicine.” Dr. Pulaski is acting director of the Parasitology Diagnostic Laboratory at the University of Georgia College of Veterinary Medicine.
Then at 3 p.m. is a presentation by Timothy Geary, PhD, on “Registration and Regulation of Veterinary Parasiticide Use: Changes Ahead?” Dr. Geary is a former director of the Institute of Parasitology at McGill University and is a member of the executive committee of the World Association for the Advancement of Veterinary Parasitology.
Dr. Jessica Rodriguez will deliver the final summit presentation at 4 p.m., titled “The Future of Parasite Control, Including Novel Interventions.” Dr. Rodriguez is a senior principal scientist in the Zoetis research and development division for veterinary medicine.